- Home
- SKIN vs IAF Comparison
SKIN vs IAF Comparison
Compare SKIN & IAF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SKIN | IAF |
|---|---|---|
| Founded | 1997 | 1985 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Package Goods/Cosmetics | Finance/Investors Services |
| Sector | Consumer Discretionary | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 123.9M | 129.2M |
| IPO Year | 2020 | N/A |
Fundamental Metrics
Financial Performance| Metric | SKIN | IAF |
|---|---|---|
| Price | $1.14 | $12.86 |
| Analyst Decision | Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $2.00 | N/A |
| AVG Volume (30 Days) | ★ 682.4K | 29.6K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | ★ 11.44% |
| EPS Growth | ★ 52.63 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $334,294,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $4.42 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.78 | $3.35 |
| 52 Week High | $2.69 | $14.54 |
Technical Indicators
Market Signals| Indicator | SKIN | IAF |
|---|---|---|
| Relative Strength Index (RSI) | 49.24 | 28.51 |
| Support Level | $0.87 | $12.72 |
| Resistance Level | $1.69 | $13.19 |
| Average True Range (ATR) | 0.08 | 0.23 |
| MACD | 0.03 | -0.17 |
| Stochastic Oscillator | 75.65 | 6.29 |
Price Performance
Historical ComparisonAbout SKIN The Beauty Health Company
The Beauty Health Co is a category-creating beauty health company that along with its subsidiaries designs, develops, manufactures, markets and sells esthetic technologies and products. The company's brand portfolio includes Hydrafacial, SkinStylus, and Keravive, offering Syndeo device, SkinStylus SteriLock Microsystem, Keravive Peptide Solution and other products.
About IAF abrdn Australia Equity Fund Inc.
Aberdeen Australia Equity Fund Inc is a non-diversified closed-end investment management company. With a core focus on long-term capital appreciation, it invests predominantly in equity securities listed on the Australian Stock Exchange. Its secondary objective is current income, which it expects to derive from dividends and interest on Australian corporate and governmental securities. Its investment portfolio comprises diversified sectors that include Financials, Health Care, Materials, Information Technology, Real Estate, and other sectors.